Umeå University's logo

umu.sePublications
System disruptions
We are currently experiencing disruptions on the search portals due to high traffic. We are working to resolve the issue, you may temporarily encounter an error message.
Change search
Link to record
Permanent link

Direct link
Publications (10 of 60) Show all publications
Duven, M., Friedrichs, A., Tomlinson, M. G., Steffen, I. & Gerold, G. (2025). Tetraspanins 10 and 15 support Venezuelan equine encephalitis virus replication in astrocytoma cells. Molecular Biology of the Cell, 36(3), Article ID 35.
Open this publication in new window or tab >>Tetraspanins 10 and 15 support Venezuelan equine encephalitis virus replication in astrocytoma cells
Show others...
2025 (English)In: Molecular Biology of the Cell, ISSN 1059-1524, E-ISSN 1939-4586, Vol. 36, no 3, article id 35Article in journal (Refereed) Published
Abstract [en]

Tetraspanins (Tspans) are transmembrane proteins that coordinate life cycle steps of viruses from distinct families. Here, we identify the human Tspan10 and Tspan15, both members of the TspanC8 subfamily, as replication factors for alphavirus Venezuelan equine encephalitis virus (VEEV) in astrocytoma cells. Pharmacological inhibition and small interfering RNA (siRNA)-mediated silencing of TspanC8 interactor a disintegrin and metalloproteinase 10 (ADAM10) reduced VEEV infection. Silencing of Tspan10, Tspan15, and ADAM10 did not affect VEEV entry but diminished viral genome replication. We report that Tspan10 is important for VEEV infection of several cell lines, while silencing of Tspan15 diminishes infection with several alphaviruses, but not flaviviruses, in astrocytoma cells. Conversely, we demonstrate that siRNA-mediated silencing of Tspan14, another member of the TspanC8 family, enhances infection with lentiviral pseudoparticles harbouring the envelope proteins of VEEV, identifying it as a restriction factor for VEEV entry. Silencing of ADAM10/Tspan15 substrate neuronal (N)-cadherin reduced VEEV infectivity, suggesting potential roles of ADAM10 substrates in VEEV infection. In sum, our study identifies three TspanC8s and ADAM10 as important modulators of VEEV infectivity.

Place, publisher, year, edition, pages
American Society for Cell Biology, 2025
National Category
Cell and Molecular Biology
Identifiers
urn:nbn:se:umu:diva-236208 (URN)10.1091/mbc.E24-12-0574 (DOI)39878649 (PubMedID)2-s2.0-85218495095 (Scopus ID)
Funder
Knut and Alice Wallenberg Foundation
Available from: 2025-03-12 Created: 2025-03-12 Last updated: 2025-03-12Bibliographically approved
Mozūraitis, R., Cirksena, K., Raftari, M., Hajkazemian, M., Mustapha Abiodun, M., Brahimi, J., . . . Emami, S. N. (2025). Zika virus modulates human fibroblasts to enhance transmission success in a controlled lab-setting. Communications Biology, 8(1), Article ID 139.
Open this publication in new window or tab >>Zika virus modulates human fibroblasts to enhance transmission success in a controlled lab-setting
Show others...
2025 (English)In: Communications Biology, E-ISSN 2399-3642, Vol. 8, no 1, article id 139Article in journal (Refereed) Published
Abstract [en]

Transmission of Zika virus (ZIKV) has been reported in 92 countries and the geographical spread of invasive virus-borne vectors has increased in recent years. Arboviruses naturally survive between vertebrate hosts and arthropod vectors. Transmission success requires the mosquito to feed on viraemic hosts. There is little specific understanding of factors that may promote ZIKV transmission-success. Here we show that mosquito host-seeking behaviour is impacted by viral infection of the vertebrae host and may be essential for the effective transmission of arboviruses like ZIKV. Human skin fibroblasts produce a variety of metabolites, and we show that ZIKV immediately alters gene/protein expression patterns in infected-dermal fibroblasts, altering their metabolism to increase the release of mosquito-attractive volatile organic compounds (VOCs), which improves its transmission success. We demonstrate that at the invasion stage, ZIKV differentially altered the emission of VOCs by significantly increasing or decreasing their amounts, while at the transmission stage of the virus, all VOCs are significantly increased. The findings are complemented by an extensive meta-proteome analysis. Overall, we demonstrate a multifaceted role of virus-host interaction and shed light on how arboviruses may influence the behaviour of their vectors as an evolved means of improving transmission-success.

Place, publisher, year, edition, pages
Nature Publishing Group, 2025
National Category
Microbiology in the Medical Area Infectious Medicine
Identifiers
urn:nbn:se:umu:diva-235717 (URN)10.1038/s42003-025-07543-9 (DOI)001410015200001 ()39885287 (PubMedID)2-s2.0-85217623533 (Scopus ID)
Funder
Knut and Alice Wallenberg Foundation
Available from: 2025-02-24 Created: 2025-02-24 Last updated: 2025-02-24Bibliographically approved
dos Reis, V. P., Cirksena, K., Rybak-Wolf, A., Seeger, B., Herker, E. & Gerold, G. (2024). 3D spheroid and organoid models to study neuroinfection of RNA viruses. In: Pierre-Yves Lozach (Ed.), Rift Valley Fever Virus: methods and protocols (pp. 409-424). Humana Press
Open this publication in new window or tab >>3D spheroid and organoid models to study neuroinfection of RNA viruses
Show others...
2024 (English)In: Rift Valley Fever Virus: methods and protocols / [ed] Pierre-Yves Lozach, Humana Press, 2024, , p. 16p. 409-424Chapter in book (Refereed)
Abstract [en]

Three-dimensional culture models of the brain enable the study of neuroinfection in the context of a complex interconnected cell matrix. Depending on the differentiation status of the neural cells, two models exist: 3D spheroids also called neurospheres and cerebral organoids. Here, we describe the preparation of 3D spheroids and cerebral organoids and give an outlook on their usage to study Rift Valley fever virus and other neurotropic viruses.

Place, publisher, year, edition, pages
Humana Press, 2024. p. 16
Series
Methods in Molecular Biology (MIMB), ISSN 1064-3745, E-ISSN 1940-6029 ; 2824
Keywords
3D spheroid, Cerebral organoid, Induced pluripotent stem cells, Neural progenitor cells, Neuroinfection, Neurosphere, Neurotropic virus
National Category
Cell and Molecular Biology
Identifiers
urn:nbn:se:umu:diva-228953 (URN)10.1007/978-1-0716-3926-9_26 (DOI)2-s2.0-85201261011 (Scopus ID)9781071639252 (ISBN)9781071639283 (ISBN)9781071639269 (ISBN)
Available from: 2024-08-30 Created: 2024-08-30 Last updated: 2024-08-30Bibliographically approved
Victoria, C., Schulz, G., Klöhn, M., Weber, S., Holicki, C. M., Brüggemann, Y., . . . Kirschning, A. (2024). Halogenated rocaglate derivatives: pan-antiviral agents against hepatitis E virus and emerging viruses. Journal of Medicinal Chemistry, 67(1), 289-321
Open this publication in new window or tab >>Halogenated rocaglate derivatives: pan-antiviral agents against hepatitis E virus and emerging viruses
Show others...
2024 (English)In: Journal of Medicinal Chemistry, ISSN 0022-2623, E-ISSN 1520-4804, Vol. 67, no 1, p. 289-321Article in journal (Refereed) Published
Abstract [en]

The synthesis of a library of halogenated rocaglate derivatives belonging to the flavagline class of natural products, of which silvestrol is the most prominent example, is reported. Their antiviral activity and cytotoxicity profile against a wide range of pathogenic viruses, including hepatitis E, Chikungunya, Rift Valley Fever virus and SARS-CoV-2, were determined. The incorporation of halogen substituents at positions 4′, 6 and 8 was shown to have a significant effect on the antiviral activity of rocaglates, some of which even showed enhanced activity compared to CR-31-B and silvestrol.

Place, publisher, year, edition, pages
American Chemical Society (ACS), 2024
National Category
Medicinal Chemistry Microbiology in the medical area
Identifiers
urn:nbn:se:umu:diva-220155 (URN)10.1021/acs.jmedchem.3c01357 (DOI)001141760200001 ()38127656 (PubMedID)2-s2.0-85181007683 (Scopus ID)
Available from: 2024-02-12 Created: 2024-02-12 Last updated: 2024-02-12Bibliographically approved
Alvarez, K. G., Goral, L., Suwandi, A., Lasswitz, L., Zapatero-Belinchón, F. J., Ehrhardt, K., . . . Grassl, G. A. (2024). Human tetraspanin CD81 facilitates invasion of Salmonella enterica into human epithelial cells. Virulence, 15(1), Article ID 2399792.
Open this publication in new window or tab >>Human tetraspanin CD81 facilitates invasion of Salmonella enterica into human epithelial cells
Show others...
2024 (English)In: Virulence, ISSN 2150-5594, E-ISSN 2150-5608, Vol. 15, no 1, article id 2399792Article in journal (Refereed) Published
Abstract [en]

Human CD81 and CD9 are members of the tetraspanin family of proteins characterized by a canonical structure of four transmembrane domains and two extracellular loop domains. Tetraspanins are known as molecular facilitators, which assemble and organize cell surface receptors and partner molecules forming clusters known as tetraspanin-enriched microdomains. They have been implicated to play various biological roles including an involvement in infections with microbial pathogens. Here, we demonstrate an important role of CD81 for the invasion of epithelial cells by Salmonella enterica. We show that the overexpression of CD81 in HepG2 cells enhances invasion of various typhoidal and non-typhoidal Salmonella serovars. Deletion of CD81 by CRISPR/Cas9 in intestinal epithelial cells (C2BBe1 and HT29-MTX-E12) reduces S. Typhimurium invasion. In addition, the effect of human CD81 is species-specific as only human but not rat CD81 facilitates Salmonella invasion. Finally, immunofluorescence microscopy and proximity ligation assay revealed that both human tetraspanins CD81 and CD9 are recruited to the entry site of S. Typhimurium during invasion but not during adhesion to the host cell surface. Overall, we demonstrate that the human tetraspanin CD81 facilitates Salmonella invasion into epithelial host cells.

Place, publisher, year, edition, pages
Taylor & Francis, 2024
Keywords
infection, intestinal epithelium, invasion, Salmonella, tetraspanins
National Category
Microbiology in the medical area
Identifiers
urn:nbn:se:umu:diva-230155 (URN)10.1080/21505594.2024.2399792 (DOI)001319914400001 ()39239914 (PubMedID)2-s2.0-85204819598 (Scopus ID)
Funder
German Research Foundation (DFG), 15898996Knut and Alice Wallenberg Foundation
Available from: 2024-10-04 Created: 2024-10-04 Last updated: 2024-10-04Bibliographically approved
Wilken, L., Lasswitz, L., Scaturro, P. & Gerold, G. (2024). Identification of RVFV host factors using quantitative interaction proteomics. In: Pierre-Yves Lozach (Ed.), Rift Valley Fever Virus: methods and protocols (pp. 189-202). Humana Press
Open this publication in new window or tab >>Identification of RVFV host factors using quantitative interaction proteomics
2024 (English)In: Rift Valley Fever Virus: methods and protocols / [ed] Pierre-Yves Lozach, Humana Press, 2024, , p. 14p. 189-202Chapter in book (Refereed)
Abstract [en]

Affinity enrichment coupled with liquid chromatography–tandem mass spectrometry (AE–LC–MS/MS) enables a comprehensive study of virus–host protein–protein interactions in cells and tissues infected with Rift Valley fever virus (RVFV) or ectopically expressing RVFV proteins. Depending on the research question, different experimental setups with carefully chosen controls are needed. Here, we describe the detailed workflow of sample preparation, processing, and cleanup, while also outlining critical points to consider when designing and performing AE–LC–MS/MS experiments.

Place, publisher, year, edition, pages
Humana Press, 2024. p. 14
Series
Methods in Molecular Biology (MIMB), ISSN 1064-3745, E-ISSN 1940-6029 ; 2824
Keywords
Affinity enrichment, Bottom-up proteomics, host interaction, Immunoprecipitation, Mass spectrometry, Protein, protein interaction, Protein purification, Virus
National Category
Medical Biotechnology (with a focus on Cell Biology (including Stem Cell Biology), Molecular Biology, Microbiology, Biochemistry or Biopharmacy)
Identifiers
urn:nbn:se:umu:diva-228949 (URN)10.1007/978-1-0716-3926-9_13 (DOI)2-s2.0-85201254936 (Scopus ID)9781071639252 (ISBN)9781071639269 (ISBN)
Available from: 2024-08-30 Created: 2024-08-30 Last updated: 2024-08-30Bibliographically approved
Passos, V., Henkel, L. M., Wang, J., Zapatero-Belinchón, F. J., Möller, R., Sun, G., . . . Viejo-Borbolla, A. (2024). Innate immune response to SARS-CoV-2 infection contributes to neuronal damage in human iPSC-derived peripheral neurons. Journal of Medical Virology, 96(2), Article ID e29455.
Open this publication in new window or tab >>Innate immune response to SARS-CoV-2 infection contributes to neuronal damage in human iPSC-derived peripheral neurons
Show others...
2024 (English)In: Journal of Medical Virology, ISSN 0146-6615, E-ISSN 1096-9071, Vol. 96, no 2, article id e29455Article in journal (Refereed) Published
Abstract [en]

Severe acute respiratory coronavirus 2 (SARS-CoV-2) causes neurological disease in the peripheral and central nervous system (PNS and CNS, respectively) of some patients. It is not clear whether SARS-CoV-2 infection or the subsequent immune response are the key factors that cause neurological disease. Here, we addressed this question by infecting human induced pluripotent stem cell-derived CNS and PNS neurons with SARS-CoV-2. SARS-CoV-2 infected a low number of CNS neurons and did not elicit a robust innate immune response. On the contrary, SARS-CoV-2 infected a higher number of PNS neurons. This resulted in expression of interferon (IFN) λ1, several IFN-stimulated genes and proinflammatory cytokines. The PNS neurons also displayed alterations characteristic of neuronal damage, as increased levels of sterile alpha and Toll/interleukin receptor motif-containing protein 1, amyloid precursor protein and α-synuclein, and lower levels of cytoskeletal proteins. Interestingly, blockade of the Janus kinase and signal transducer and activator of transcription pathway by Ruxolitinib did not increase SARS-CoV-2 infection, but reduced neuronal damage, suggesting that an exacerbated neuronal innate immune response contributes to pathogenesis in the PNS. Our results provide a basis to study coronavirus disease 2019 (COVID-19) related neuronal pathology and to test future preventive or therapeutic strategies.

Place, publisher, year, edition, pages
John Wiley & Sons, 2024
Keywords
interferon, iPSC-derived peripheral neurons, JAK/STAT, neuronal damage, SARM1, SARS-CoV-2
National Category
Neurosciences Infectious Medicine Immunology in the medical area
Identifiers
urn:nbn:se:umu:diva-221106 (URN)10.1002/jmv.29455 (DOI)38323709 (PubMedID)2-s2.0-85184531658 (Scopus ID)
Funder
German Research Foundation (DFG), 458632757German Research Foundation (DFG), 390874280German Research Foundation (DFG), 158989968
Available from: 2024-02-27 Created: 2024-02-27 Last updated: 2024-02-27Bibliographically approved
Matthaei, A., Joecks, S., Frauenstein, A., Bruening, J., Bankwitz, D., Friesland, M., . . . Pietschmann, T. (2024). Landscape of protein-protein interactions during hepatitis C virus assembly and release. Microbiology Spectrum, 12(2), Article ID e0256222.
Open this publication in new window or tab >>Landscape of protein-protein interactions during hepatitis C virus assembly and release
Show others...
2024 (English)In: Microbiology Spectrum, E-ISSN 2165-0497, Vol. 12, no 2, article id e0256222Article in journal (Refereed) Published
Abstract [en]

Assembly of infectious hepatitis C virus (HCV) particles requires multiple cellular proteins including for instance apolipoprotein E (ApoE). To describe these protein-protein interactions, we performed an affinity purification mass spectrometry screen of HCV-infected cells. We used functional viral constructs with epitope-tagged envelope protein 2 (E2), protein (p) 7, or nonstructural protein 4B (NS4B) as well as cells expressing a tagged variant of ApoE. We also evaluated assembly stage-dependent remodeling of protein complexes by using viral mutants carrying point mutations abrogating particle production at distinct steps of the HCV particle production cascade. Five ApoE binding proteins, 12 p7 binders, 7 primary E2 interactors, and 24 proteins interacting with NS4B were detected. Cell-derived PREB, STT3B, and SPCS2 as well as viral NS2 interacted with both p7 and E2. Only GTF3C3 interacted with E2 and NS4B, highlighting that HCV assembly and replication complexes exhibit largely distinct interactomes. An HCV core protein mutation, preventing core protein decoration of lipid droplets, profoundly altered the E2 interactome. In cells replicating this mutant, E2 interactions with HSPA5, STT3A/B, RAD23A/B, and ZNF860 were significantly enhanced, suggesting that E2 protein interactions partly depend on core protein functions. Bioinformatic and functional studies including STRING network analyses, RNA interference, and ectopic expression support a role of Rad23A and Rad23B in facilitating HCV infectious virus production. Both Rad23A and Rad23B are involved in the endoplasmic reticulum (ER)-associated protein degradation (ERAD). Collectively, our results provide a map of host proteins interacting with HCV assembly proteins, and they give evidence for the involvement of ER protein folding machineries and the ERAD pathway in the late stages of the HCV replication cycle.IMPORTANCEHepatitis C virus (HCV) establishes chronic infections in the majority of exposed individuals. This capacity likely depends on viral immune evasion strategies. One feature likely contributing to persistence is the formation of so-called lipo-viro particles. These peculiar virions consist of viral structural proteins and cellular lipids and lipoproteins, the latter of which aid in viral attachment and cell entry and likely antibody escape. To learn about how lipo-viro particles are coined, here, we provide a comprehensive overview of protein-protein interactions in virus-producing cells. We identify numerous novel and specific HCV E2, p7, and cellular apolipoprotein E-interacting proteins. Pathway analyses of these interactors show that proteins participating in processes such as endoplasmic reticulum (ER) protein folding, ER-associated protein degradation, and glycosylation are heavily engaged in virus production. Moreover, we find that the proteome of HCV replication sites is distinct from the assembly proteome, suggesting that transport process likely shuttles viral RNA to assembly sites.

Place, publisher, year, edition, pages
American Society for Microbiology, 2024
Keywords
affinity purification, endoplasmic reticulum, ERAD, hepatitis C virus, host-pathogen interactions, HSPA5, lipoproteins, proteomics, Rad23B, viral assembly and release, virus-host interactions
National Category
Microbiology in the medical area
Identifiers
urn:nbn:se:umu:diva-221113 (URN)10.1128/spectrum.02562-22 (DOI)001143555400001 ()38230952 (PubMedID)2-s2.0-85184516987 (Scopus ID)
Funder
German Research Foundation (DFG), 158989968German Research Foundation (DFG), GE 2145/3-2Knut and Alice Wallenberg FoundationGerman Research Foundation (DFG), 390874280
Available from: 2024-02-19 Created: 2024-02-19 Last updated: 2024-02-19Bibliographically approved
Bley, H., Krisp, C., Schöbel, A., Hehner, J., Schneider, L., Becker, M., . . . Herker, E. (2024). Proximity labeling of host factor ANXA3 in HCV infection reveals a novel LARP1 function in viral entry. Journal of Biological Chemistry, 300(5), Article ID 107286.
Open this publication in new window or tab >>Proximity labeling of host factor ANXA3 in HCV infection reveals a novel LARP1 function in viral entry
Show others...
2024 (English)In: Journal of Biological Chemistry, ISSN 0021-9258, E-ISSN 1083-351X, Vol. 300, no 5, article id 107286Article in journal (Refereed) Published
Abstract [en]

Hepatitis C virus (HCV) infection is tightly connected to the lipid metabolism with lipid droplets (LDs) serving as assembly sites for progeny virions. A previous LD proteome analysis identified annexin A3 (ANXA3) as an important HCV host factor that is enriched at LDs in infected cells and required for HCV morphogenesis. To further characterize ANXA3 function in HCV, we performed proximity labeling using ANXA3-BioID2 as bait in HCV-infected cells. Two of the top proteins identified proximal to ANXA3 during HCV infection were the La-related protein 1 (LARP1) and the ADP ribosylation factor-like protein 8B (ARL8B), both of which have been previously described to act in HCV particle production. In follow-up experiments, ARL8B functioned as a pro-viral HCV host factor without localizing to LDs and thus likely independent of ANXA3. In contrast, LARP1 interacts with HCV core protein in an RNA-dependent manner and is translocated to LDs by core protein. Knockdown of LARP1 decreased HCV spreading without altering HCV RNA replication or viral titers. Unexpectedly, entry of HCV particles and E1/E2-pseudotyped lentiviral particles was reduced by LARP1 depletion, whereas particle production was not altered. Using a recombinant vesicular stomatitis virus (VSV)ΔG entry assay, we showed that LARP1 depletion also decreased entry of VSV with VSV, MERS, and CHIKV glycoproteins. Therefore, our data expand the role of LARP1 as an HCV host factor that is most prominently involved in the early steps of infection, likely contributing to endocytosis of viral particles through the pleiotropic effect LARP1 has on the cellular translatome.

Place, publisher, year, edition, pages
Elsevier, 2024
Keywords
Hepatitis C virus (HCV), host-pathogen interaction, lipid droplets, proteomics, proximity labeling, virus entry
National Category
Microbiology in the medical area
Identifiers
urn:nbn:se:umu:diva-225955 (URN)10.1016/j.jbc.2024.107286 (DOI)38636657 (PubMedID)2-s2.0-85192670056 (Scopus ID)
Funder
German Research Foundation (DFG)
Available from: 2024-06-12 Created: 2024-06-12 Last updated: 2024-06-12Bibliographically approved
Haid, S., Matthaei, A., Winkler, M., Sake, S. M., Gunesch, A. P., Milke, V., . . . Pietschmann, T. (2024). Repurposing screen identifies novel candidates for broad-spectrum coronavirus antivirals and druggable host targets. Antimicrobial Agents and Chemotherapy, 68(3), Article ID e01210-23.
Open this publication in new window or tab >>Repurposing screen identifies novel candidates for broad-spectrum coronavirus antivirals and druggable host targets
Show others...
2024 (English)In: Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, E-ISSN 1098-6596, Vol. 68, no 3, article id e01210-23Article in journal (Refereed) Published
Abstract [en]

Libraries composed of licensed drugs represent a vast repertoire of molecules modulating physiological processes in humans, providing unique opportunities for the discovery of host-targeting antivirals. We screened the Repurposing, Focused Rescue, and Accelerated Medchem (ReFRAME) repurposing library with approximately 12,000 molecules for broad-spectrum coronavirus antivirals and discovered 134 compounds inhibiting an alphacoronavirus and mapping to 58 molecular target categories. Dominant targets included the 5-hydroxytryptamine receptor, the dopamine receptor, and cyclin-dependent kinases. Gene knock-out of the drugs’ host targets including cathepsin B and L (CTSB/L; VBY-825), the aryl hydrocarbon receptor (AHR; Phortress), the farnesyl-diphosphate farnesyltransferase 1 (FDFT1; P-3622), and the kelch-like ECH-associated protein 1 (KEAP1; Omaveloxolone), significantly modulated HCoV-229E infection, providing evidence that these compounds inhibited the virus through acting on their respective host targets. Counter-screening of all 134 primary compound candidates with SARS-CoV-2 and validation in primary cells identified Phortress, an AHR activating ligand, P-3622-targeting FDFT1, and Omaveloxolone, which activates the NFE2-like bZIP transcription factor 2 (NFE2L2) by liberating it from its endogenous inhibitor KEAP1, as antiviral candidates for both an Alpha- and a Betacoronavirus. This study provides an overview of HCoV-229E repurposing candidates and reveals novel potentially druggable viral host dependency factors hijacked by diverse coronaviruses.

Place, publisher, year, edition, pages
American Society for Microbiology, 2024
Keywords
antivirals, coronavirus, CRISPR/Cas9, HCoV-229E, host-targeting antiviral therapy, repurposing, SARS-CoV-2
National Category
Biochemistry Molecular Biology
Identifiers
urn:nbn:se:umu:diva-222422 (URN)10.1128/aac.01210-23 (DOI)001158282200001 ()38319076 (PubMedID)2-s2.0-85187004901 (Scopus ID)
Funder
German Research Foundation (DFG), 158989968German Research Foundation (DFG), 417852234Knut and Alice Wallenberg Foundation
Available from: 2024-03-28 Created: 2024-03-28 Last updated: 2025-02-20Bibliographically approved
Organisations
Identifiers
ORCID iD: ORCID iD iconorcid.org/0000-0002-1326-5038

Search in DiVA

Show all publications